These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11159506)

  • 41. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
    Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
    Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Zonal cortical scarring and tubular thyroidization in kidney biopsies of patients with SLE-histologic indicator for antiphospholipid antibodies.
    Shah R; Brodsky SV; Hebert L; Rovin BH; Nadasdy T; Satoskar AA
    Lupus; 2018 Dec; 27(14):2236-2244. PubMed ID: 30403144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrent miscarriage is not associated with a higher prevalence of inherited and acquired thrombophilia.
    Vomstein K; Herzog A; Voss P; Feil K; Goeggl T; Strowitzki T; Toth B; Kuon RJ
    Am J Reprod Immunol; 2021 Jan; 85(1):e13327. PubMed ID: 32860294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of acquired and hereditary risk factors for the development of thromboembolism in patients with systemic lupus erythematosus.
    Gürsoy V; Sadri S; Ermurat S
    Blood Coagul Fibrinolysis; 2023 Dec; 34(8):478-486. PubMed ID: 37756208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiphospholipid antibodies impact the protein C (PC) pathway behavior.
    Gennari LC; Blanco AN; Alberto MF; Grosso SH; Peirano AA; Lazzari MA
    Am J Hematol; 2002 Oct; 71(2):128-30. PubMed ID: 12353314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody.
    Matsuda J; Saitoh N; Gohchi K; Gotoh M; Tsukamoto M
    Am J Hematol; 1994 Sep; 47(1):56-8. PubMed ID: 8042617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Mouzas IA; Maladaki A; Kapsoritakis A; Roussomoustakaki M; Kouroumalis EA; Manousos ON
    Am J Gastroenterol; 2000 Jan; 95(1):190-4. PubMed ID: 10638581
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies.
    Mello G; Parretti E; Martini E; Mecacci F; La Torre P; Cioni R; Lucchetti R; Fedi S; Gori AM; Pepe G; Prisco D; Abbate R
    Haemostasis; 1999; 29(4):197-203. PubMed ID: 10702700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thrombophilia and thrombosis in systemic lupus erythematosus: a case-control study.
    Barcat D; Guérin V; Ryman A; Constans J; Vernhes JP; Vergnes C; Bonnet F; Delbrel X; Morlat P; Longy-Boursier M; Conri C
    Ann Rheum Dis; 2003 Oct; 62(10):1016-7. PubMed ID: 12972486
    [No Abstract]   [Full Text] [Related]  

  • 52. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J; Kuratsune H; Suehisa E; Iwatani Y; Kanakura Y
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence of thromboembolic events in patients with primary Sjögren's syndrome.
    Haga HJ; Jacobsen EM; Peen E
    Scand J Rheumatol; 2008; 37(2):127-9. PubMed ID: 18415770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.
    Herranz MT; Rivier G; Khamashta MA; Blaser KU; Hughes GR
    Arthritis Rheum; 1994 Apr; 37(4):568-71. PubMed ID: 8147935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
    Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
    Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
    Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
    Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
    Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Postiglione A; De Chiara S; Soricelli A; Oriente A; Ruocco A; Spadaro G; Montefusco S; Marone G; Genovese A
    Int J Clin Lab Res; 1998; 28(1):34-8. PubMed ID: 9594361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiphospholipid antibodies in paediatric systemic lupus erythematosus, juvenile chronic arthritis and overlap syndromes: SLE patients with both lupus anticoagulant and high-titre anticardiolipin antibodies are at risk for clinical manifestations related to the antiphospholipid syndrome.
    Gattorno M; Buoncompagni A; Molinari AC; Barbano GC; Morreale G; Stalla F; Picco P; Mori PG; Pistoia V
    Br J Rheumatol; 1995 Sep; 34(9):873-81. PubMed ID: 7582730
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for activated protein C resistance before oral contraceptive treatment: a pilot study.
    Palareti G; Legnani C; Frascaro M; Flamigni C; Gammi L; Gola G; Fuschini G; Coccheri S
    Contraception; 1999 May; 59(5):293-9. PubMed ID: 10494482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.